<< Back to Results
Centocor Ortho-Biotech – A Phase II Single Arm Study of Carboplatin and DOXIL plus Bevacizumab in Subjects with Platinum Sensitive Recurrent Ovarian, Fallopian Tube and Primary Peritoneal Cancer
-
Clinical Trial Categories
- Contact
- Hanjani Institute for Gynecologic Oncology at 215-885-0220
Location
- Hanjani Institute for Gynecologic Oncology
The Rosenfeld Cancer Center
1200 Old York Rd, AMH - 1 Widener
Abington, PA 19001
Office: 215-885-0220
Fax: 215-576-0740